HLA-B27 Genotyping, Ankylosing Spondylitis
Ankylosing spondylitis (AS) is an inflammatory disease with unknown etiology that mainly affects the axial skeleton, but other organs (lung, kidney, and eyes, among others) and peripheral joints are also frequently involved. AS is often characterized by lower back pain and stiffness, as well as arthritis in the spine, knees, hips, and shoulders. Other symptoms include fever, fatigue, loss of appetite, weight loss, and anemia. AS can result in inflammation and tissue damage in other organs, including the eyes, lungs, heart, and kidneys.
There is a strong association between the HLA-B27 allele and AS. HLA-B27 belongs to the major histocompatibility complex class I antigens, encoded by the B locus located on the short arm of chromosome 6. HLA-B27 is used for the diagnosis of ankylosing spondylitis (AS), and it can be also used as an aid in the diagnosis of other inflammatory autoimmune diseases such as Reiter syndrome, reactive arthritis, juvenile rheumatoid arthritis (JRA), and uveitis.
Testing for HLA-B27 can be performed by serotyping, by molecular methods, or genotyping. Genotyping is a common method because it can detect various alleles and subtypes of HLA-B27 antigen that might be significant for disease diagnosis. HLA-B27 by itself contains more than 30 alleles or subtypes of which only subtypes B2705, B2704, and HLA-B*2702 are strongly associated with AS. It is recommended that family members of those with the disease who are HLA-B27 positive be screened for HLA-B27 for early disease diagnosis and management.
Diagnosis of AS is strongly suggested by typical symptoms, a positive family history, and presence of the HLA-B27 antigen. In a study published in 2007, two additional genes were found to be involved in the pathogenesis of AS; they are the ARTS-1 and IL23R genes. These three genes together are involved in about 70% of AS cases. About 8% of the unaffected population carries the HLA-B27 gene, but not everyone with the gene has AS. In fact, only about 90% of AS patients have it.
- Diagnosis of ankylosing spondylitis
- Management of ankylosing spondylitis
- Exclusion of spondyloarthritis and other related ankylosing spondylitis autoimmune diseases
One copy of the HLA-B*27 antigen has been shown to be associated with AS and related disorders.
If the HLA-B27 antigen is not identified, this does not rule out AS, as 10 percent of affected patients are not HLA-B27 positive.
HLA-B27 genotyping is not a definitive test for diagnosis of AS or other aforementioned disorders. HLA-B27 positivity must be present with symptoms such as chronic back pain, stiffness, spinal curvature, inflammation, and/or degenerative bone changes (seen on X-ray) supports the diagnosis.
Differential diagnosis of HLA-B27 positivity:
- Spondyloarthritis
- Ankylosing spondylitis (>90%)
- Reiter syndrome (>80%)
- Juvenile rheumatoid arthritis (>80%)
- Reactive arthritis (75%)
- Acute anterior uveitis (>50%)
- Infection with enteric organisms, such as Yersinia, Shigella, or Salmonella
- Deficiency of complement components C2 and C4
- Adrenal hyperplasia
- Inflammatory bowel disease
- Some other autoimmune diseases (<20%)
Negative for HLA-B27
Whole blood collected with anticoagulants (EDTA purple top tube most common used), Buccal swab.
Stability
- 5 days: ambient
- 7 days: refrigerated
- Harrison’s Rheumatology (McGraw-Hill). 2010;129-143.
- Rheumatology (Mosby). 2011;1141-1143.
- J Clin Rheumatol. 2008 Feb;14(1):50-2. [PMID: 18431102]
- Arthritis Res. 2002;4 Suppl 3:S153-8. [PMID: 12110134]
- Ann Intern Med. 2002;136:896. [PMID: 12069564]
- Immunogenetics. 1999 Nov;50(3-4):220-7. [PMID: 10602882]
- Rheumatology (Oxford). 2002;41:857. [PMID: 12154202]